Fca Corp Cognition Therapeutics Inc Transaction History
Fca Corp
- $304 Million
- Q1 2025
A detailed history of Fca Corp transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Fca Corp holds 51,471 shares of CGTX stock, worth $14,411. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,471
Previous 51,471
-0.0%
Holding current value
$14,411
Previous $38,000
44.74%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
14MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.68 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$617,5050.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$346,9660.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$282,1240.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$170,3490.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $6.36M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...